Bio Medica Laboratories logo

Bio Medica Laboratories

BMLL NSE

Key Fundamentals

SMEPharmaceuticalsHealthcare
Market Cap
₹197 Cr
Volatility
Moderate
P/E Ratio
16.9
EBITDA
₹18.38 Cr
Return on Equity
66.48%
Debt to Equity
1.54
Book Value
₹58.61
52W High
₹181
52W Low
₹101.5

Tapetide Score

Data-driven rating, 0–100. How it works →

Growth Rate

Revenue Growth
0% lower than 3Y
Net Income Growth
17.96% lower than 3Y
Cash Flow Change
-327% lower than 3Y
ROE
31.38% lower than 3Y
ROCE
82.15% lower than 3Y
EBITDA Margin (Avg.)
19.49% lower than 3Y

Quarterly Results

Particulars Mar 2026
Sales
43
Expenses
23
Operating Profit
20
OPM %
46%
Other Income
0
Interest
2
Depreciation
1
PBT
16
Tax %
27%
Net Profit
12
EPS in Rs
13.06
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2026
Sales
43
Expenses
23
Operating Profit
20
OPM %
46%
Other Income
0
Interest
2
Depreciation
1
PBT
16
Tax %
27%
Net Profit
12
EPS in Rs
13.06
Div. Payout %
0%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2026
Equity Capital
9
Reserves
17
Borrowings
40
Other Liabilities
7
Total Liabilities
73
Fixed Assets
17
CWIP
0
Investments
0
Other Assets
56
Total Assets
73
Figures in ₹ Crores

Cash Flow

Particulars Mar 2026
Operating
-6
Investing
-2
Financing
8
Net Cash Flow
0
Free Cash Flow
-8
CFO/OP
-9
Figures in ₹ Crores

Ratios

Particulars Mar 2026
Debtor Days
92
Inventory Days
759
Days Payable
116
Cash Conversion Cycle
735
Working Capital Days
300

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Bio Medica Laboratories insights

29 extracted metrics + investor summaries across FY23–FY25.

Log in — free

Shareholding Pattern

FIIs0.29%Promot.67.70%DIIs2.31%Others8.33%Public21.38%As ofMay 2026

Documents

Frequently Asked Questions about Bio Medica Laboratories

What does Bio Medica Laboratories Ltd do?
Incorporated in August 2015, Bio Medica Laboratories Ltd specialises in manufacturing pharmaceutical parenteral formulations, producing a wide range of ethical drugs, generic drugs, and over-the -counter (OTC) medications[1]
Where is Bio Medica Laboratories Ltd (BMLL) listed?
Bio Medica Laboratories Ltd trades as BMLL on the NSE.
Which sector does Bio Medica Laboratories Ltd belong to?
Bio Medica Laboratories Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Bio Medica Laboratories Ltd?
Bio Medica Laboratories Ltd has a market capitalisation of ₹197.43 Cr, which places it in the Small Cap band.
What is the PE ratio of Bio Medica Laboratories Ltd?
Bio Medica Laboratories Ltd trades at a PE ratio of 16.90, against a book value of ₹58.61 per share.
What is the 52-week high and low of Bio Medica Laboratories Ltd?
Over the last 52 weeks Bio Medica Laboratories Ltd has traded between ₹101.5 and ₹181.
What is the Return on Equity (ROE) of Bio Medica Laboratories Ltd?
Bio Medica Laboratories Ltd reported a return on equity of 66.48%. Its debt-to-equity ratio is 1.54.

Company Information

Incorporated in August 2015, Bio Medica Laboratories Ltd specialises in manufacturing pharmaceutical parenteral formulations, producing a wide range of ethical drugs, generic drugs, and over-the -counter (OTC) medications[1]

Listed 2026-05-29
Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/BMLL.md for Bio Medica Laboratories Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More